Comparison of the efficacy and safety of platelet-rich-plasma and autologous-serum eye drops in primary Sjögren syndrome dry eyes

Not Applicable

Completed

• Conditions: Diseases of the musculoskeletal system and connective tissue

• Registration Number: KCT0008103
• Lead Sponsor: The Catholic University of Korea, Seoul St. Mary's Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2019-08-30
• Last Update Posted: 8 February 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 36

Inclusion Criteria

Moderate to severe dry eye who diagnosed as Sjogren syndrome

Exclusion Criteria

patients who had other systemic diseases, who had received other eye drops, systemic steroid or immunosuppressive treatment within the previous three months, who had undergone ocular surgery within the previous three months

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Corneal and conjunctival staining scores

Secondary Outcome Measures

Name	Time	Method
Corneal and conjunctival staining scores;Schirmer I value ;Tear break up time;Ocular Surface Disease Index;Conjunctival impression cytology metaplasia and goblet-cell density